NDC product
Arthritis Pain Reliever
NDC 59726-012 · P & L Development, LLC
Key facts
| Product NDC | 59726-012 |
|---|---|
| Proprietary name | Arthritis Pain Reliever |
| Nonproprietary name | Diclofenac sodium |
| Substances | DICLOFENAC SODIUM |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | P & L Development, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA208077 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| Marketing start | Jun 25, 2021 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: